日本の医療用食品市場レポート：製品、投与経路、用途、流通チャネル、地域別、2025年～2033年

日本の医療用食品市場規模は2024年に11億米ドルに達しました。今後、IMARC Groupは、2033年には19億米ドルに達し、2025年から2033年にかけて5.5%の成長率（CAGR）を示すと予測しています。急速に進む高齢化と国全体の高度なヘルスケアシステム、疾病状態における食事管理の重要性に対する国民の意識の高まり、食品科学における技術革新が市場を牽引する主な要因のいくつかです。

本レポートで扱う主な質問

• 日本の医療用食品市場はこれまでどのように推移し、今後どのように推移するのか？
• COVID-19が日本の医療用食品市場に与えた影響は？
• 日本の医療用食品市場の製品別内訳は？
• 日本の医療用食品市場の投与経路別の内訳は？
• 日本の医療用食品市場の用途別内訳は？
• 日本の医療用食品市場の流通チャネル別の内訳は？
• 日本の医療用食品市場のバリューチェーンにおける各ステージとは？
• 日本の医療用食品の主要な促進要因と課題は何か？
• 日本の医療用食品市場の構造と主要プレーヤーは？
• 日本の医療用食品市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
• 市場推定
• 調査手法

第3章 エグゼクティブサマリー

第4章 日本の医療用食品市場-イントロダクション

• 概要
• 市場力学
• 業界動向
• 競合情報

第5章 日本の医療用食品市場情勢

• 過去および現在の市場動向（2019～2024年）
• 市場予測（2025～2033年）

第6章 日本の医療用食品市場- 製品別の内訳

• 錠剤
• 粉
• その他

第7章 日本の医療用食品市場- 投与経路別の内訳

• 経口
• 経腸

第8章 日本の医療用食品市場- 用途別の内訳

• ADHD
• うつ
• 糖尿病
• がん
• アルツハイマー病
• 代謝障害
• その他

第9章 日本の医療用食品市場- 流通チャネル別の内訳

• スーパーマーケット
• 病院および薬局
• オンライン薬局
• その他

第10章 日本の医療用食品市場- 競合情勢

• 概要
• 市場構造
• 市場企業のポジショニング
• 主要成功戦略
• 競合ダッシュボード
• 企業評価象限

第11章 主要企業のプロファイル

第12章 日本の医療用食品市場- 業界分析

• 促進要因・抑制要因・機会
• ポーターのファイブフォース分析
• バリューチェーン分析

第13章 付録

Japan medical foods market size reached USD 1.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 1.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.5% during 2025-2033. The rapidly aging population and advanced healthcare systems across the country, heightened public awareness about the importance of dietary management in disease conditions, and technological innovations in food science represent some of the key factors driving the market.

Medical foods are specially formulated and processed products intended for the dietary management of patients with a medical condition or disease. These products are designed to be consumed or administered under the supervision of a healthcare provider. Unlike conventional foods, medical foods are not meant for the general population. They address the unique nutritional needs arising from specific medical conditions, such as diabetes, metabolic disorders, or chronic kidney disease. They are formulated to meet specific nutritional requirements that cannot be achieved by modifying a normal diet. However, it is essential to note that medical foods are not pharmaceuticals, nor are they intended to treat or cure diseases. They function primarily to manage symptoms and conditions, thereby improving the quality of life for patients. As a result, medical foods are gaining immense traction as an integral part of patient care and healthcare strategies across Japan and the world.

Japan Medical Foods Market Trends:

The Japan medical foods market is currently experiencing growth due to a multitude of factors. One of the primary drivers is the country's rapidly aging population. Japan has one of the highest proportions of elderly citizens globally, which naturally leads to an increase in age-related medical conditions like Alzheimer's, diabetes, and chronic kidney disease. This, in turn, has augmented the demand for medical foods as they serve as an important dietary management tool for these ailments. Additionally, the high healthcare standard in Japan represents another major growth-inducing factor. The country's healthcare system is robust and advanced, making it more receptive to integrating medical foods as part of a comprehensive patient care strategy. Healthcare providers are increasingly recommending these specialized foods, creating a sense of trust and acceptance among consumers, thus accelerating product adoption rates. Moreover, technological advancements in the field of food science are significantly contributing to the market growth. Innovations are allowing for the development of more effective and palatable medical foods, which are tailored to meet specific dietary restrictions and nutritional needs. This enhances patient compliance, further fueling market growth. Besides this, the heightened public awareness and education about the importance of dietary management in disease conditions, owing to favorable government initiatives and the role of digital media, is propelling market growth. This has led to more informed choices, with people actively seeking medical foods as a supplementary management option. Furthermore, the regulatory environment in Japan supports stringent quality checks and balances, ensuring that only safe and effective products make it to the market. This regulatory assurance further instills confidence among consumers and healthcare providers alike, thereby driving market growth. Apart from this, strategic collaborations between food manufacturers and healthcare organizations that facilitate research and development (R&D) activities, resulting in product diversification and improvements, are fostering market growth.

Japan Medical Foods Market Segmentation:

Product Insights:

• Pills
• Powder
• Others

Route of Administration Insights:

• Oral
• Enteral

Application Insights:

• ADHD
• Depression
• Diabetes
• Cancer
• Alzheimer's Disease
• Metabolic Disorders
• Others

Distribution Channel Insights:

• Supermarkets
• Hospital and Retail Pharmacies
• Online Pharmacies
• Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan medical foods market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan medical foods market?
• What is the breakup of the Japan medical foods market on the basis of product?
• What is the breakup of the Japan medical foods market on the basis of route of administration?
• What is the breakup of the Japan medical foods market on the basis of application?
• What is the breakup of the Japan medical foods market on the basis of distribution channel?
• What are the various stages in the value chain of the Japan medical foods market?
• What are the key driving factors and challenges in the Japan medical foods?
• What is the structure of the Japan medical foods market and who are the key players?
• What is the degree of competition in the Japan medical foods market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Medical Foods Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Medical Foods Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Medical Foods Market - Breakup by Product

• 6.1 Pills
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Powder
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Others
  • 6.3.1 Historical and Current Market Trends (2019-2024)
  • 6.3.2 Market Forecast (2025-2033)

7 Japan Medical Foods Market - Breakup by Route of Administration

• 7.1 Oral
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Enteral
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)

8 Japan Medical Foods Market - Breakup by Application

• 8.1 ADHD
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Depression
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Diabetes
  • 8.3.1 Overview
  • 8.3.2 Historical and Current Market Trends (2019-2024)
  • 8.3.3 Market Forecast (2025-2033)
• 8.4 Cancer
  • 8.4.1 Overview
  • 8.4.2 Historical and Current Market Trends (2019-2024)
  • 8.4.3 Market Forecast (2025-2033)
• 8.5 Alzheimer's Disease
  • 8.5.1 Overview
  • 8.5.2 Historical and Current Market Trends (2019-2024)
  • 8.5.3 Market Forecast (2025-2033)
• 8.6 Metabolic Disorders
  • 8.6.1 Overview
  • 8.6.2 Historical and Current Market Trends (2019-2024)
  • 8.6.3 Market Forecast (2025-2033)
• 8.7 Others
  • 8.7.1 Historical and Current Market Trends (2019-2024)
  • 8.7.2 Market Forecast (2025-2033)

9 Japan Medical Foods Market - Breakup by Distribution Channel

• 9.1 Supermarkets
  • 9.1.1 Overview
  • 9.1.2 Historical and Current Market Trends (2019-2024)
  • 9.1.3 Market Forecast (2025-2033)
• 9.2 Hospital and Retail Pharmacies
  • 9.2.1 Overview
  • 9.2.2 Historical and Current Market Trends (2019-2024)
  • 9.2.3 Market Forecast (2025-2033)
• 9.3 Online Pharmacies
  • 9.3.1 Overview
  • 9.3.2 Historical and Current Market Trends (2019-2024)
  • 9.3.3 Market Forecast (2025-2033)
• 9.4 Others
  • 9.4.1 Historical and Current Market Trends (2019-2024)
  • 9.4.2 Market Forecast (2025-2033)

10 Japan Medical Foods Market - Competitive Landscape

• 10.1 Overview
• 10.2 Market Structure
• 10.3 Market Player Positioning
• 10.4 Top Winning Strategies
• 10.5 Competitive Dashboard
• 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

• 11.1 Company A
  • 11.1.1 Business Overview
  • 11.1.2 Product Portfolio
  • 11.1.3 Business Strategies
  • 11.1.4 SWOT Analysis
  • 11.1.5 Major News and Events
• 11.2 Company B
  • 11.2.1 Business Overview
  • 11.2.2 Product Portfolio
  • 11.2.3 Business Strategies
  • 11.2.4 SWOT Analysis
  • 11.2.5 Major News and Events
• 11.3 Company C
  • 11.3.1 Business Overview
  • 11.3.2 Product Portfolio
  • 11.3.3 Business Strategies
  • 11.3.4 SWOT Analysis
  • 11.3.5 Major News and Events
• 11.4 Company D
  • 11.4.1 Business Overview
  • 11.4.2 Product Portfolio
  • 11.4.3 Business Strategies
  • 11.4.4 SWOT Analysis
  • 11.4.5 Major News and Events
• 11.5 Company E
  • 11.5.1 Business Overview
  • 11.5.2 Product Portfolio
  • 11.5.3 Business Strategies
  • 11.5.4 SWOT Analysis
  • 11.5.5 Major News and Events

12 Japan Medical Foods Market - Industry Analysis

• 12.1 Drivers, Restraints, and Opportunities
  • 12.1.1 Overview
  • 12.1.2 Drivers
  • 12.1.3 Restraints
  • 12.1.4 Opportunities
• 12.2 Porters Five Forces Analysis
  • 12.2.1 Overview
  • 12.2.2 Bargaining Power of Buyers
  • 12.2.3 Bargaining Power of Suppliers
  • 12.2.4 Degree of Competition
  • 12.2.5 Threat of New Entrants
  • 12.2.6 Threat of Substitutes
• 12.3 Value Chain Analysis

13 Appendix